MRK
Price
$85.48
Change
+$1.36 (+1.62%)
Updated
Sep 2 closing price
Capitalization
213.51B
57 days until earnings call
SNY
Price
$49.59
Change
+$0.11 (+0.22%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
121.19B
52 days until earnings call
Interact to see
Advertisement

MRK vs SNY

Header iconMRK vs SNY Comparison
Open Charts MRK vs SNYBanner chart's image
Merck & Co
Price$85.48
Change+$1.36 (+1.62%)
Volume$11.64M
Capitalization213.51B
Sanofi ADS
Price$49.59
Change+$0.11 (+0.22%)
Volume$48.13K
Capitalization121.19B
MRK vs SNY Comparison Chart in %
Loading...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRK vs. SNY commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a StrongBuy and SNY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (MRK: $84.12 vs. SNY: $49.48)
Brand notoriety: MRK: Notable vs. SNY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 88% vs. SNY: 110%
Market capitalization -- MRK: $213.51B vs. SNY: $120.68B
MRK [@Pharmaceuticals: Major] is valued at $213.51B. SNY’s [@Pharmaceuticals: Major] market capitalization is $120.68B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $659.07B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 2 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • MRK’s FA Score: 2 green, 3 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, MRK is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 5 TA indicator(s) are bullish while SNY’s TA Score has 7 bullish TA indicator(s).

  • MRK’s TA Score: 5 bullish, 4 bearish.
  • SNY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SNY is a better buy in the short-term than MRK.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а -3.72% price change this week, while SNY (@Pharmaceuticals: Major) price change was -3.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.29%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was +10.10%.

Reported Earning Dates

MRK is expected to report earnings on Oct 30, 2025.

SNY is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.29% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($214B) has a higher market cap than SNY($121B). SNY has higher P/E ratio than MRK: SNY (16.50) vs MRK (13.17). SNY YTD gains are higher at: 7.138 vs. MRK (-13.856). MRK has higher annual earnings (EBITDA): 25B vs. SNY (12.6B). SNY has more cash in the bank: 15.4B vs. MRK (8.62B). SNY has less debt than MRK: SNY (22.3B) vs MRK (35.4B). MRK has higher revenues than SNY: MRK (63.6B) vs SNY (45.7B).
MRKSNYMRK / SNY
Capitalization214B121B177%
EBITDA25B12.6B198%
Gain YTD-13.8567.138-194%
P/E Ratio13.1716.5080%
Revenue63.6B45.7B139%
Total Cash8.62B15.4B56%
Total Debt35.4B22.3B159%
FUNDAMENTALS RATINGS
MRK vs SNY: Fundamental Ratings
MRK
SNY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
7569
SMR RATING
1..100
2761
PRICE GROWTH RATING
1..100
5960
P/E GROWTH RATING
1..100
9193
SEASONALITY SCORE
1..100
2n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (4) in the Pharmaceuticals Major industry is in the same range as MRK (9). This means that SNY’s stock grew similarly to MRK’s over the last 12 months.

SNY's Profit vs Risk Rating (69) in the Pharmaceuticals Major industry is in the same range as MRK (75). This means that SNY’s stock grew similarly to MRK’s over the last 12 months.

MRK's SMR Rating (27) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNY (61). This means that MRK’s stock grew somewhat faster than SNY’s over the last 12 months.

MRK's Price Growth Rating (59) in the Pharmaceuticals Major industry is in the same range as SNY (60). This means that MRK’s stock grew similarly to SNY’s over the last 12 months.

MRK's P/E Growth Rating (91) in the Pharmaceuticals Major industry is in the same range as SNY (93). This means that MRK’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKSNY
RSI
ODDS (%)
Bearish Trend 5 days ago
49%
Bearish Trend 5 days ago
42%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
61%
Bullish Trend 5 days ago
49%
Momentum
ODDS (%)
Bearish Trend 5 days ago
56%
Bearish Trend 5 days ago
46%
MACD
ODDS (%)
Bearish Trend 5 days ago
53%
Bullish Trend 5 days ago
45%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
50%
Bearish Trend 5 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
47%
Bullish Trend 5 days ago
50%
Advances
ODDS (%)
Bullish Trend 12 days ago
47%
Bullish Trend 12 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
52%
Bearish Trend 5 days ago
49%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
70%
Aroon
ODDS (%)
Bullish Trend 5 days ago
58%
Bullish Trend 5 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALSN87.31-0.43
-0.49%
Allison Transmission Holdings
KAVA.X0.372623-0.003270
-0.87%
Kava cryptocurrency
XVS.X6.194226-0.130270
-2.06%
Venus cryptocurrency
ATA.X0.043454-0.000916
-2.06%
Automata Network cryptocurrency
AST.X0.033077-0.001923
-5.49%
AirSwap cryptocurrency

MRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been loosely correlated with PFE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.09%
PFE - MRK
58%
Loosely correlated
+0.65%
BMY - MRK
50%
Loosely correlated
+0.64%
BIIB - MRK
50%
Loosely correlated
-0.32%
NVS - MRK
48%
Loosely correlated
+0.06%
AZN - MRK
47%
Loosely correlated
-0.11%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with GSK. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
-0.92%
GSK - SNY
55%
Loosely correlated
+0.58%
NVS - SNY
54%
Loosely correlated
+0.06%
PFE - SNY
49%
Loosely correlated
+0.65%
AZN - SNY
49%
Loosely correlated
-0.11%
MRK - SNY
44%
Loosely correlated
+1.09%
More